(1 - 7 from 10
)
Celera sees path to profit in gene map - Baltimore Sun
www.baltimoresun.com
Jun 24, — As a result, admirers such as Wall Street analyst Winton Gibbons of William Blair & Co. say Celera is poised "to become the leading supplier ... › news › bs-xpm
Celera lays off Washington Times
www.washingtontimes.com
But the company is in a better position to take advantage of the genetic database than other drug makers, Winton Gibbons, an analyst at ...
Genome project yields intriguing results - Houston Chronicle
www.chron.com
William Blair & Co. analyst Winton Gibbons said the quality of Celera's genome description appears to be "quite superior." "I think Celera will ...
Post-election lift for pharma, biotech - MarketWatch
www.marketwatch.com
William Blair analyst Winton Gibbons, who tracks a wide variety of companies that include Pfizer and Celera Genomics , sees both sectors as getting a bit of a boost from
sorted by relevance / date